- Home
- PRLD vs SFWL Comparison
PRLD vs SFWL Comparison
Compare PRLD & SFWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRLD
- SFWL
- Stock Information
- Founded
- PRLD 2016
- SFWL 2001
- Country
- PRLD United States
- SFWL China
- Employees
- PRLD N/A
- SFWL 1263
- Industry
- PRLD Medicinal Chemicals and Botanical Products
- SFWL Trucking Freight/Courier Services
- Sector
- PRLD Health Care
- SFWL Industrials
- Exchange
- PRLD Nasdaq
- SFWL Nasdaq
- Market Cap
- PRLD 73.7M
- SFWL 74.2M
- IPO Year
- PRLD 2020
- SFWL 2023
- Fundamental
- Price
- PRLD $0.81
- SFWL $0.90
- Analyst Decision
- PRLD Strong Buy
- SFWL
- Analyst Count
- PRLD 2
- SFWL 0
- Target Price
- PRLD $4.50
- SFWL N/A
- AVG Volume (30 Days)
- PRLD 279.1K
- SFWL 12.4K
- Earning Date
- PRLD 05-06-2025
- SFWL 04-29-2025
- Dividend Yield
- PRLD N/A
- SFWL N/A
- EPS Growth
- PRLD N/A
- SFWL 4.79
- EPS
- PRLD N/A
- SFWL 0.13
- Revenue
- PRLD $7,000,000.00
- SFWL $504,158,000.00
- Revenue This Year
- PRLD N/A
- SFWL N/A
- Revenue Next Year
- PRLD N/A
- SFWL N/A
- P/E Ratio
- PRLD N/A
- SFWL $6.83
- Revenue Growth
- PRLD N/A
- SFWL 24.75
- 52 Week Low
- PRLD $0.61
- SFWL $0.81
- 52 Week High
- PRLD $6.80
- SFWL $2.18
- Technical
- Relative Strength Index (RSI)
- PRLD 57.52
- SFWL 38.24
- Support Level
- PRLD $0.71
- SFWL $0.87
- Resistance Level
- PRLD $0.72
- SFWL $0.95
- Average True Range (ATR)
- PRLD 0.08
- SFWL 0.06
- MACD
- PRLD 0.02
- SFWL -0.01
- Stochastic Oscillator
- PRLD 76.92
- SFWL 20.63
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.
About SFWL Shengfeng Development Limited
Shengfeng Development Ltd is a holding company. Through its subsidiaries, it offers contract logistics services in China. The contract logistics services offered by the company include planning and designing supply chains, designing facilities, processing orders, collecting payments, managing inventories, and providing client services.